<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04612127</url>
  </required_header>
  <id_info>
    <org_study_id>UCAMCFE-00016</org_study_id>
    <nct_id>NCT04612127</nct_id>
  </id_info>
  <brief_title>Efficacy of the Consumption of a Spinach Extract on Muscle Function in Subjects Over 50 Years of Age</brief_title>
  <acronym>SPISAR</acronym>
  <official_title>Nutritional Clinical Trial to Evaluate the Efficacy of Daily Consumption for 12 Weeks of a Spinach Extract on Muscle Function in Subjects Over 50 Years of Age</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Católica San Antonio de Murcia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad Católica San Antonio de Murcia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Controlled, randomized, single-center, double-blind clinical trial, with two parallel&#xD;
      branches depending on the product consumed, to measure the efficacy of a supplement extracted&#xD;
      from spinach on muscle strength in subjects over 50 years of age.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects who meet the selection criteria will make two visits to the laboratory to perform&#xD;
      the tests established in the protocol. In addition, all subjects will develop a program of&#xD;
      strength, polyarticular, individualized and progressive exercises in which the main muscle&#xD;
      groups are worked. The program will be held three days a week (36 sessions). Subsequently, a&#xD;
      statistical analysis will be performed with the variables measured in the study to obtain&#xD;
      results.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 14, 2020</start_date>
  <completion_date type="Actual">July 31, 2021</completion_date>
  <primary_completion_date type="Actual">June 8, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Muscle function</measure>
    <time_frame>From baseline to 90 days</time_frame>
    <description>Isokinetic dynamometry. Knee flexion and extension force</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle function</measure>
    <time_frame>From baseline to 90 days</time_frame>
    <description>Isometric dynamometry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle mass</measure>
    <time_frame>From baseline to 90 days</time_frame>
    <description>Dual X-ray absorptiometry (DEXA), measured in grams.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle mass</measure>
    <time_frame>From baseline to 90 days</time_frame>
    <description>Bioimpedance, in grams.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Balance</measure>
    <time_frame>From baseline to 90 days</time_frame>
    <description>Force platform Kistler</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Questionnaire</measure>
    <time_frame>From baseline to 90 days</time_frame>
    <description>Questionnaire Quality of life SF-36. It consists of 36 questions that assess the health and well-being of the person</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional survey</measure>
    <time_frame>From baseline to 90 days</time_frame>
    <description>24 hour memory</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver safety variables</measure>
    <time_frame>It is measured on an empty stomach, before and after the consumption time (60 days) with the experimental product and the placebo product.</time_frame>
    <description>It is a blood test blood, with the aim of determining if there is any alteration in the liver.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Sarcopenia</condition>
  <condition>Physical Exercise</condition>
  <arm_group>
    <arm_group_label>Experimental group - Spinach</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consumption for 90 days of spinach extract (1000mg)&#xD;
Four capsules will be consumed per day, two with breakfast and two with lunch.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group Placebo (sucrose)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Four capsules will be consumed per day, two with breakfast and two with lunch.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary supplement consumption and physical exercise</intervention_name>
    <description>The consumption time of the experimental product was 90 days and the control consumption time was 90 days.&#xD;
During this time, training should be done three times a week.</description>
    <arm_group_label>Experimental group - Spinach</arm_group_label>
    <arm_group_label>control group Placebo (sucrose)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 50 and 75 years.&#xD;
&#xD;
          -  Body mass index less than 32.&#xD;
&#xD;
          -  Subjects who do not develop physical exercise scheduled on a weekly basis.&#xD;
&#xD;
          -  Subjects who have given written informed consent to participate in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Consumption during the 6 months prior to the study of functional food or supplement&#xD;
             that modifies body composition.&#xD;
&#xD;
          -  Presence of absolute or relative contraindications dictated by the American College of&#xD;
             Sports Medicine, for the performance of physical exercise.&#xD;
&#xD;
          -  Presence of chronic diseases that prevent the performance of a physical exercise&#xD;
             program (disabling arthropathies, moderate / severe chronic lung disease, ischemic&#xD;
             heart disease under treatment, arrhythmias, etc.).&#xD;
&#xD;
          -  Abuse in the ingestion of alcohol.&#xD;
&#xD;
          -  Present hypersensitivity or intolerance to any of the components of the products under&#xD;
             study.&#xD;
&#xD;
          -  Inability to understand informed consent.&#xD;
&#xD;
          -  Serious or terminal illnesses.&#xD;
&#xD;
          -  Subjects with a body mass index above 32.&#xD;
&#xD;
          -  Pregnant or lactating women.&#xD;
&#xD;
          -  Inability to understand informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Catholic University of Murcia</name>
      <address>
        <city>Murcia</city>
        <zip>30107</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2020</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Católica San Antonio de Murcia</investigator_affiliation>
    <investigator_full_name>Francisco Javier López Román</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sarcopenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

